Archives

by in
Entry Author Date Location
Wisconsin Roundup: Cellular Dynamics, Baird, Health Apps, & More 04/24/15 Wisconsin
West Coast Biotech Roundup: Juno, Genervon, Tekmira, DNANexus & More 04/23/15 Seattle
Spirox Inhales $18.5M to Advance Nasal Surgery Device 04/21/15 San Francisco
Alnylam RNAi Drug Holds Up After Year of Treatment in Small Study 04/21/15 Boston
Xbiotech’s $76M Offering Sets Course for Late-Stage Cancer Studies 04/15/15 Texas
HAP Innovations Tackles Missed Meds with Automated Dispenser 04/14/15 Raleigh Durham
East Coast Biotech Roundup: Cellectis, Bristol, What’s Hot & More 04/13/15 Boston
West Coast Biotech Roundup: Juno, Tekmira, True North, aTyr & More 04/10/15 Seattle
Edge Brings in VC Backers, Gets $72.5M For Head Injury Drug 04/09/15 New York
Prenatal Screener Natera Grabs $55M, Considers Cancer Test 04/06/15 San Francisco
Cancer Groups Tap The Crowd To Boost Clinical Trial Participation 04/01/15 Wisconsin
Garabedian’s Rocky Road at Sarepta Ends With Abrupt Resignation 04/01/15 Boston
Fresh Off Boston Move, CoLucid Plots IPO For Migraine Drug Push 03/31/15 Raleigh Durham
Pivoting From IPO, Syndax Inks Combo Trial Deal With Merck 03/31/15 Boston
Horizon Pays $1.1 Billion for Hyperion’s Rare Disease Drugs 03/30/15 San Francisco
Gelesis Bags $22M More, Ramps Up Trials for Weight-Loss Pill 03/26/15 Boston
Stop the Bleeding: Can Gene Therapy Finally Cure Hemophilia? 03/23/15 National
Somna Makes Case for Simple Device Before Drugs, Surgery for Reflux 03/19/15 Wisconsin
Ginkgo Bioworks Grabs $9M Series A For Building Organisms 03/18/15 Boston
With Asklepion Deal, Retrophin Gets a New Drug—And a Voucher 03/18/15 New York
Business Analytics Firm Birst Brings In $65M Series F 03/17/15 San Francisco
In Mental Health Therapy, Cautious Steps Toward the Pharmacodigital 03/17/15 National
Admetsys Wins Top Prize at SXSW Hatch Pitch, Astroprint and Plum Follow 03/16/15 Texas
East Coast Biotech Roundup: Sync Project, Epizyme, Bristol & More 03/16/15 Boston
23andMe Adds On: More About The Gene-Test Maker’s Drug R&D Ambitions 03/12/15 San Francisco
Allergen Takes $80M Series B for Phase 3 Peanut Allergy Trial 03/12/15 San Francisco
Medical Adhesive Revolution Aims for a Better Wound-Sealing Therapy 03/12/15 Texas
23andMe Pharma? That’s the Plan, Says the Genetic Test Maker 03/12/15 San Francisco
At Acadia, “Mistakes Were Made,” A Drug Is Delayed & the CEO Is Out 03/11/15 San Diego
Stratatech Eyes Phase 3 Trial Of Regenerative Tissue For Burn Wounds 03/11/15 Wisconsin
Page 1 of 44 next page »